Hyaluronic Acid-Functionalized Nanomicelles Enhance SAHA Efficacy in 3D Endometrial Cancer Models
Histone Deacetylase (HDAC) enzymes are upregulated in cancer leading to the development of HDAC inhibiting compounds, several of which are currently in clinical trials. Side effects associated with toxicity and non-specific targeting indicate the need for efficient drug delivery approaches and tumor...
Main Authors: | Kadie Edwards, Seydou Yao, Simone Pisano, Veronica Feltracco, Katja Brusehafer, Sumanta Samanta, Oommen P. Oommen, S. Andrea Gazze, Roberta Paravati, Holly Maddison, Chao Li, Deyarina Gonzalez, R. Steven Conlan, Lewis Francis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/4032 |
Similar Items
-
Phosphorus containing analogues of SAHA as inhibitors of HDACs
by: Michael D. Pun, et al.
Published: (2022-12-01) -
Futbolda farklı saha zeminlerinin kas hasarı üzerine etkisi
by: Aydin Karabulak, et al.
Published: (2023-06-01) -
Histone Deacetylase Inhibitor (SAHA) Reduces Mortality in an Endotoxemia Mouse Model by Suppressing Glycolysis
by: Yunchen Wu, et al.
Published: (2023-08-01) -
Hyaluronic acid in gynecology and obstetrics
by: Anna Małgorzata Łopuszyńska, et al.
Published: (2022-04-01) -
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms
by: Bo Tu, et al.
Published: (2020-02-01)